
News|Articles|July 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 6, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of June 29, 2022, at 4:00 AM, EDT:
47.8% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.9% of total US population
• 71.2% of US population aged ≥5 years
• 75.3% of US population aged ≥12 years
• 76.8% of US population aged ≥18 years
• 91.5% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, July 6, 2022 at 3:21 PM, EDT, there have been:
• 88 174 713 confirmed cases and
• 1 018 695 deaths
• 592 514 756 total vaccine doses administered
• 1 018 695 deaths
• 592 514 756 total vaccine doses administered
In the past 28 days, the 3 states with the most new cases are:
1. California: 481 868
2. Florida: 297 072
3. Texas: 247 481
2. Florida: 297 072
3. Texas: 247 481
Deaths: California has the highest number of deaths due to COVID-19 with 92 479 reported fatalities, followed by Texas with 88 784 and Florida with 76 031.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 552 019 693 confirmed cases, 6 343 626 deaths, and 11 759 439 682 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears First At-Home Brain-Stimulation Device for Major Depression
2
Retatrutide Achieves Up to 28.7% Weight Loss and Marked Knee Pain Reduction in Phase 3 TRIUMPH-4 Trial
3
ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management
4
FDA Opens Safety Review of RSV Monoclonal Antibodies Used in Infants
5





















































































































































































































































































